Skip to content
Corner Daily Maastricht

The Zimbabwean Government Declines ‘One-Sided’ American Health Aid Package Because of Information Concerns

Medical funding image
The offered American financial assistance would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has declined a significant US health deal worth $367m (£272m) spanning five years because of the United States' demand for sensitive data.

This move became public following a government memo dated December was leaked, which showed President Emmerson Mnangagwa deemed the deal was "lopsided".

A government representative has since explained that the US was demanding access to health data for research and commercial purposes while was not willing to share the benefits from any future treatments.

"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the US had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for further negotiations to reach a agreement acceptable to both sides so the country's critical HIV programme can proceed.

Broader Implications

This rejection follows a comparable situation in neighbouring Kenya, where a court halted a similar deal with the US following concerns were raised about the security of citizens' medical information.

Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

USAID had managed aid for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing government-to-government deals to enhance openness and accountability.

As per statements, 16 nations in Africa have to date signed similar health pacts, representing more than $18.3bn of fresh investment.

Details of the Declined Agreement

The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this cooperation might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy via American-funded initiatives," Tremont added.

However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".

"Zimbabwe was being asked to share its genetic material and health information for a long time, with no corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.

"In essence, our country would provide the raw materials for scientific discovery without any certainty that the end products would be accessible to our population if a future pandemic emerge."

Sovereignty and Global Health

He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting structures already set up through the international health agency.

Mangwana cited its Pandemic Benefit-Sharing system designed to deal with future pandemics.

"This framework is intended to guarantee that when a nation provides its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to create them."

Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We encourage continued discussions with our US partners on how future co-operation could be structured in a manner that honours the sovereignty and dignity of both nations."

Medical Community Response

A leading public health body said it understood the official position, but urged that negotiations must proceed since much of the country's Aids initiatives were funded by external financing.

"Where specific concerns exist, such as those relating to data governance or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," it said.

The situation highlights the ongoing challenges between accepting vital foreign assistance and safeguarding a country's data in an increasingly data-driven world.

Written by

Rebecca Woods

Lena is a freelance journalist based in Maastricht, covering local culture and community stories.

Corner Daily Maastricht

Type to search articles.